Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 1
1996 1
1997 1
2000 1
2001 2
2003 5
2004 2
2005 3
2006 8
2007 7
2008 3
2009 8
2010 7
2011 3
2012 3
2013 4
2014 3
2015 7
2016 7
2017 15
2018 3
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 15100370

89 results
Results by year
Filters applied: . Clear all
Page 1
Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population.
Smith DH, Gullion CM, Nichols G, Keith DS, Brown JB. Smith DH, et al. J Am Soc Nephrol. 2004 May;15(5):1300-6. doi: 10.1097/01.asn.0000125670.64996.bb. J Am Soc Nephrol. 2004. PMID: 15100370 Free article.
All-cause costs increase exponentially with increased chronic kidney disease stage.
Golestaneh L, Alvarez PJ, Reaven NL, Funk SE, McGaughey KJ, Romero A, Brenner MS, Onuigbo M. Golestaneh L, et al. Am J Manag Care. 2017 Jun;23(10 Suppl):S163-S172. Am J Manag Care. 2017. PMID: 28978205 Free article.
Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA, Cai Q, Buono JL, Spalding WM, Sarocco P, Tan H, Stephenson JJ, Carson RT. Doshi JA, et al. J Manag Care Spec Pharm. 2014 Apr;20(4):382-90. doi: 10.18553/jmcp.2014.20.4.382. J Manag Care Spec Pharm. 2014. PMID: 24684643
Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.
Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL. Gandra SR, et al. J Manag Care Pharm. 2006 Sep;12(7):546-54. doi: 10.18553/jmcp.2006.12.7.546. J Manag Care Pharm. 2006. PMID: 16981800
Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
Buono JL, Mathur K, Averitt AJ, Andrae DA. Buono JL, et al. J Manag Care Spec Pharm. 2017 Apr;23(4):453-460. doi: 10.18553/jmcp.2016.16138. Epub 2016 Nov 21. J Manag Care Spec Pharm. 2017. PMID: 28345443
Clinical and economic outcomes in Medicare beneficiaries with stage 3 or stage 4 chronic kidney disease and anemia: the role of intravenous iron therapy.
Knight TG, Ryan K, Schaefer CP, D'Sylva L, Durden ED. Knight TG, et al. J Manag Care Pharm. 2010 Oct;16(8):605-15. doi: 10.18553/jmcp.2010.16.8.605. J Manag Care Pharm. 2010. PMID: 20866165
Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
Eriksson JK, Neovius M, Jacobson SH, Elinder CG, Hylander B. Eriksson JK, et al. BMJ Open. 2016 Oct 7;6(10):e012062. doi: 10.1136/bmjopen-2016-012062. BMJ Open. 2016. PMID: 27855091 Free PMC article.
Economic burden of patients with anemia in selected diseases.
Ershler WB, Chen K, Reyes EB, Dubois R. Ershler WB, et al. Value Health. 2005 Nov-Dec;8(6):629-38. doi: 10.1111/j.1524-4733.2005.00058.x. Value Health. 2005. PMID: 16283863 Free article.
Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure.
Polson M, Lord TC, Kangethe A, Speicher L, Farnum C, Brenner M, Oestreicher N, Alvarez P. Polson M, et al. J Manag Care Spec Pharm. 2017 Apr;23(4-a Suppl):S2-S9. doi: 10.18553/jmcp.2017.23.4-a.s2. J Manag Care Spec Pharm. 2017. PMID: 28436256
Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns.
Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP. Nissenson AR, et al. J Am Soc Nephrol. 2001 Aug;12(8):1713-20. J Am Soc Nephrol. 2001. PMID: 11461944 Free article.
89 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback